XML 21 R11.htm IDEA: XBRL DOCUMENT v3.20.2
5. STOCK-BASED COMPENSATION
3 Months Ended
Sep. 30, 2020
Share-based Payment Arrangement [Abstract]  
STOCK-BASED COMPENSATION
5. STOCK-BASED COMPENSATION

 

The following table summarizes stock-based compensation expense for the three months ended September 30, 2020 and 2019:

 

    Three Months
Ended September 30,
 
    2020     2019  
Cost of Goods Sold   $ 11,233     $ 11,233  
Research and Development Expenses     16,925       12,684  
Selling, General and Administrative Expenses     42,988       52,588  
    $ 71,146     $ 76,505  

  

No compensation has been capitalized because such amounts would have been immaterial.

 

The following tables summarize stock option activity for the three months ended September 30, 2020:

 

    Options Outstanding
    Number of
Shares
    Weighted Average
Exercise Price
    Weighted Average
Contractual Life
Outstanding at July 1, 2020     2,065,200     $ 0.95     6.59 years
Outstanding at September 30, 2020     2,065,200     $ 0.95     6.34 years

 

Information related to the stock options outstanding as of September 30, 2020 is as follows:

 

Range of
Exercise Prices
  Number of
Shares
    Weighted-
Average
Remaining
Contractual Life
(years)
    Weighted-
Average
Exercise Price
    Exercisable
Number of
Shares
    Exercisable
Weighted-
Average
Exercise Price
 
$ 0.27       40,000       0.79     $ 0.27       40,000     $ 0.27  
$ 0.48       60,000       5.50     $ 0.48       60,000     $ 0.48  
$ 0.50       100,000       4.72     $ 0.50       100,000     $ 0.50  
$ 0.55       44,000       3.46     $ 0.55       44,000     $ 0.55  
$ 0.70       100,000       7.84     $ 0.70       100,000     $ 0.70  
$ 0.73       786,000       6.06     $ 0.73       786,000     $ 0.73  
$ 0.85       6,000       2.26     $ 0.85       6,000     $ 0.85  
$ 0.90       36,000       3.69     $ 0.90       36,000     $ 0.90  
$ 1.20       200,200       1.42     $ 1.20       200,200     $ 1.20  
$ 1.25       45,000       9.47     $ 1.25           $  
$ 1.30       478,000       8.63     $ 1.30       160,679     $ 1.30  
$ 1.42       100,000       8.94     $ 1.42       33,334     $ 1.42  
$ 1.50       70,000       9.19     $ 1.50       70,000     $ 1.50  
$ 0.27–1.50       2,065,200       6.34     $ 0.95       1,636,213     $ 0.85  

 

The aggregate intrinsic value of the Company’s “in-the-money” outstanding and exercisable options as of the three months ended September 30, 2020 was $435,520.